Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (65 ops.)
Latest filing published 11 May 2018 for Krystal Biotech, Inc., €79k.
Filing timeline
BuySaleR. Douglas Norby
Insider track record
Disclosed buys
1
Disclosed sells
65
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +253.7%Entry US$10.10 · Close at T+365 US$35.72
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
R. Douglas Norby: trading record in brief
R. Douglas Norby has filed trades across 6 companies (mainly through SEC (Form 4)), most often in Alexion Pharmaceuticals Inc, Tessera Technologies Inc and MAGNACHIP SEMICONDUCTOR Corp. The record holds 115 filings, for trades running from 9 January 2006 to 9 May 2018.
In open-market terms, that means 1 purchase worth €79k on one side and 65 sales worth €23.2M on the other. On balance, insiders were net sellers of €23.1M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 20 share grants and 27 option exercises. So far in 2018, the count stands at 1 purchase and no sales.
The newest entry dates from 11 May 2018: an open-market purchase of €79k, in Krystal Biotech, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to R. Douglas Norby
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations112 total
9,000 shares@ US$10.42100.0% of flowCommon StockSEC:0001209191-18-029567:0
Canonical exit: 7 Aug 2018 (T+90)
2,030 shares0Common Stock, par value $.0001 per shareSEC:0000899866-17-000112:0
7,202 shares@ US$128.8146.1% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000361:0
2,800 shares@ US$130.0318.1% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000361:1
3,724 shares@ US$131.1024.2% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000361:2
1,774 shares@ US$131.9711.6% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-16-000361:3
835 shares0Common Stock, par value $.0001 per shareSEC:0000899866-16-000307:0
6,314 shares0Common StockSEC:0000899243-16-016171:0
13,000 shares@ US$18.01Common Stock, par value $.0001 per shareSEC:0000899866-15-000213:0
12,276 shares@ US$16.83Common Stock, par value $.0001 per shareSEC:0000899866-15-000213:1
7,932 shares@ US$26.64Common Stock, par value $.0001 per shareSEC:0000899866-15-000213:2
5,572 shares@ US$49.43Common Stock, par value $.0001 per shareSEC:0000899866-15-000213:3
3,237 shares@ US$85.75Common Stock, par value $.0001 per shareSEC:0000899866-15-000213:4
3,425 shares@ US$96.35Common Stock, par value $.0001 per shareSEC:0000899866-15-000213:5
34 shares@ US$186.97Common Stock, par value $.0001 per shareSEC:0000899866-15-000213:6
35,575 shares@ US$187.57Common Stock, par value $.0001 per shareSEC:0000899866-15-000213:7
9,833 shares@ US$188.24Common Stock, par value $.0001 per shareSEC:0000899866-15-000213:8
7,853 shares0Common StockSEC:0001209191-15-052439:0
7,853 shares0Common StockSEC:0001209191-15-052439:1
700 shares0Common Stock, par value $.0001 per shareSEC:0000899866-15-000111:0
895 shares0Common StockSEC:0000899866-14-000087:0
24,363 shares0Common Stock, par value $.0001 per shareSEC:0000899866-13-000185:0
23,000 shares@ US$10.84Common Stock, par value $.0001 per shareSEC:0000899866-13-000122:0
17,000 shares@ US$18.01Common Stock, par value $.0001 per shareSEC:0000899866-13-000122:1
24,204 shares@ US$104.03Common Stock, par value $.0001 per shareSEC:0000899866-13-000122:2
25 of 112 declarations
